News Related to Medullary Thyroid Cancer

Related coverage linked through entity extraction aliases.

GLP-1 Receptor Agonists Linked to Hair Loss Risk, Survival Benefits in Brain Metastases

Mar 13, 2026

Recent studies examine safety profiles of GLP-1 receptor agonists, finding increased risk for nonscarring hair loss but improved survival in patients with brain metastases and type 2 diabetes.

Selpercatinib Shows Significant Survival Benefit in Early-Stage RET Fusion-Positive Lung Cancer

Feb 17, 2026

Phase 3 LIBRETTO-432 trial met its primary endpoint, showing selpercatinib delivered statistically significant and clinically meaningful improvement in event-free survival versus placebo as adjuvant therapy in early-stage RET fusion-positive NSCLC.